Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate [version 2; peer review: 2 approved]
Background: This study aims to determine the factors affecting HBV DNA suppression in chronic hepatitis B patients with tenofovir disoproxil fumarate (TDF). Methods: A case-control was carried out from October 2021 to August 2022 on 182 chronic hepatitis B patients who had TDF therapy regularly for...
| Հիմնական հեղինակներ: | , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
F1000 Research Ltd
2023-08-01
|
| Շարք: | F1000Research |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://f1000research.com/articles/11-1521/v2 |